InvestorsHub Logo

rawman

03/23/20 9:42 AM

#62507 RE: VST7 #62468

I suggest reading the linked document!

DECN's coronavirus testing technology relies on "IMPEDANCE", which IS NOT A CURRENTLY ACCEPTED CANDIDATE for an FDA EUA Waiver.

The only currently approved serologic test method is based on detecting blood-borne anti-bodies. DECN's process does not actually detect blood-borne anti-bodies.

Per the FDA, the DECN approach can be defined as an "Alternative Technology" and, per the linked document, is a candidate to be "discussed" with the FDA.

Jelly Bean

03/23/20 12:57 PM

#62738 RE: VST7 #62468

Thanks for the link. But, I doubt Berman will meet these requirements and I don't see where in this document it gives the manufacturer carte blanc to sell non-validated testing